Jim Simons
CLBT icon

Jim Simons’s Cellebrite CLBT Stock Holding History

Jim Simons’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4M Sell
2,150,239
-710,400
-25% -$9.39M 0.04% 513
2026
Q1 		$39.4M Buy
2,860,639
+365,700
+15% +$5.51M 0.06% 396
2025
Q4 		$45M Sell
2,494,939
-407,166
-14% -$7.31M 0.07% 320
2025
Q3 		$53.8M Buy
2,902,105
+215,766
+8% +$3.39M 0.07% 329
2025
Q2 		$43M Buy
2,686,339
+76,000
+3% +$1.35M 0.06% 395
2025
Q1 		$50.7M Buy
2,610,339
+979,900
+60% +$20.6M 0.08% 316
2024
Q4 		$35.9M Buy
1,630,439
+115,939
+8% +$2.23M 0.05% 433
2024
Q3 		$25.5M Buy
1,514,500
+330,800
+28% +$4.91M 0.04% 558
2024
Q2 		$14.1M Buy
1,183,700
+214,600
+22% +$2.4M 0.02% 750
2024
Q1 		$10.7M Sell
969,100
-82,056
-8% -$838K 0.02% 954
2023
Q4 		$9.1M Buy
1,051,156
+727,756
+225% +$5.66M 0.01% 995
2023
Q3 		$2.47M Buy
323,400
+126,100
+64% +$946K ﹤0.01% 1732
2023
Q2 		$1.42M Buy
197,300
+120,700
+158% +$704K ﹤0.01% 2221
2023
Q1 		$466K Buy
76,600
+63,300
+476% +$343K ﹤0.01% 2920
2022
Q4 		$58K Buy
+13,300
New +$59.4K ﹤0.01% 3769

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Voss Capital
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Pertento Partners
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Jim Simons's CLBT Position: Q2 2026 in Review

Jim Simons reduced its Cellebrite (CLBT) stake by 25% in Q2 2026, selling an estimated $9.39M and leaving 2,150,239 shares worth $31.4M. The position accounts for 0.04% of the portfolio, ranked #513.

Jim Simons first reported a position in CLBT in Q4 2022 and has held it in 15 quarters since. The position peaked at $53.8M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Jim Simons held 2,150,239 shares of Cellebrite worth $31.4M as of Q2 2026.
  • Jim Simons sold 710,400 Cellebrite shares in Q2 2026, an estimated $9.39M.
  • Cellebrite made up 0.04% of Jim Simons's portfolio in Q2 2026, its #513 holding.
  • Jim Simons first reported a position in Cellebrite in Q4 2022 and has held it in 15 quarters since.
  • Jim Simons's Cellebrite position peaked at $53.8M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.